90 related articles for article (PubMed ID: 8797875)
1. Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.
Würl P; Taubert H; Bache M; Kroll J; Meye A; Berger D; Siermann A; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Int J Cancer; 1996 Aug; 69(4):317-23. PubMed ID: 8797875
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of p53 gene in childhood malignant solid tumors.
Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
[TBL] [Abstract][Full Text] [Related]
4. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
[TBL] [Abstract][Full Text] [Related]
6. The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.
Taubert H; Würl P; Bache M; Meye A; Berger D; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Anticancer Res; 1998; 18(1A):183-7. PubMed ID: 9568075
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas.
Hall KL; Teneriello MG; Taylor RR; Lemon S; Ebina M; Linnoila RI; Norris JH; Park RC; Birrer MJ
Gynecol Oncol; 1997 May; 65(2):330-5. PubMed ID: 9159347
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor genes and related molecules in leiomyosarcoma.
Dei Tos AP; Maestro R; Doglioni C; Piccinin S; Libera DD; Boiocchi M; Fletcher CD
Am J Pathol; 1996 Apr; 148(4):1037-45. PubMed ID: 8644845
[TBL] [Abstract][Full Text] [Related]
9. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.
Koga H; Zhang S; Ichikawa T; Washiyama K; Kuroiwa T; Tanaka R; Kumanishi T
Noshuyo Byori; 1994; 11(2):151-5. PubMed ID: 7894617
[TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
12. p53 status in radiation-induced soft-tissue sarcomas.
Taubert H; Meye A; Bache M; Hinze R; Holzhausen HJ; Schmidt H; Rath FW; Dunst J; Würl P
Strahlenther Onkol; 1998 Aug; 174(8):427-30. PubMed ID: 9739384
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
14. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
15. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
Felix CA; Kappel CC; Mitsudomi T; Nau MM; Tsokos M; Crouch GD; Nisen PD; Winick NJ; Helman LJ
Cancer Res; 1992 Apr; 52(8):2243-7. PubMed ID: 1559227
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
17. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
18. Results of p53 analysis in pediatric malignancies in Poland.
Fiszer-Maliszewska Ł; Czernik J; Sawicz-Birkowska K; Kazanowska B; Wojciechowska B
Med Pediatr Oncol; 2003 May; 40(5):316-21. PubMed ID: 12652620
[TBL] [Abstract][Full Text] [Related]
19. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
[TBL] [Abstract][Full Text] [Related]
20. Predominant p53 G-->A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine.
Trukhanova LS; Hong HH; Sills RC; Bowser AD; Gaul B; Boorman GA; Turusov VS; Devereux TR; Dixon D
Toxicol Pathol; 1998; 26(3):367-74. PubMed ID: 9608642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]